News tagged with ribavirin therapy
Depression overlooked in patients with hepatitis C; compromising HCV therapy
Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, ...
Medicine & Health / Diseases, Conditions, Syndromes
Jul 20, 2010 |
not rated yet |
0
Search results for ribavirin therapy
US approves second new hepatitis C drug
The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month.
Medicine & Health / Medications
May 23, 2011 |
not rated yet |
0
US regulators approve new hepatitis C drug
US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.
Medicine & Health / Medications
May 14, 2011 |
not rated yet |
2
US panel gives nod to Merck hepatitis C drug
A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.
Medicine & Health / Medications
Apr 27, 2011 |
5 / 5 (1) |
0
FDA says Merck drug successfully fights hepatitis
Federal health officials said Monday a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years. But the agency has questions ...
Medicine & Health / Medications
Apr 25, 2011 |
not rated yet |
0
Data suggest liver experts should take care when prescribing novel antiviral HCV drugs
Data presented at the International Liver Congress highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 02, 2011 |
not rated yet |
0
PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a
Highly exciting new data presented today at the International Liver CongressTM found Pegylated Interferon-lambda (PegIFN-lambda) shows superior virological response in HCV patients of genotypes 1-4, with improved safety and ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 02, 2011 |
not rated yet |
0
Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
Berlin, Germany, Saturday 02 April 2011: Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 02, 2011 |
not rated yet |
0
The future looks bright for HCV patients who have failed to respond to current treatments
Berlin, Germany, Friday 1st April 2011: Highly anticipated data from a number of clinical trials presented for the first time at the International Liver CongressTM confirmed that a range of new proteases inhibitors will help ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 01, 2011 |
5 / 5 (1) |
0
Drug cocktail offers new hope for hepatitis C patients
A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital.
Medicine & Health / Diseases, Conditions, Syndromes
Mar 30, 2011 |
5 / 5 (1) |
0
|
Game changer: Hepatitis C drug may revolutionize treatment
The drug boceprevir helps cure hard-to-treat hepatitis C, says Saint Louis University investigator Bruce R. Bacon, M.D., author of the March 31 New England Journal of Medicine article detailing the study's findings. The re ...
Medicine & Health / Diseases, Conditions, Syndromes
Mar 30, 2011 |
3 / 5 (2) |
0
List of search results for ribavirin therapy
